|
Quality Id |
Measure Name |
High Priority |
Measure Type |
Measure Description |
|
012 |
Primary
Open-Angle Glaucoma (POAG): Optic Nerve Evaluation |
No |
Process |
Percentage
of patients aged 18 years and older with a diagnosis of primary open-angle
glaucoma (POAG) who have an optic nerve head evaluation during one or more
office visits within 12 months |
|
014 |
Age-Related
Macular Degeneration (AMD): Dilated Macular Examination |
No |
Process |
Percentage
of patients aged 50 years and older with a diagnosis of age-related macular
degeneration (AMD) who had a dilated macular examination performed which
included documentation of the presence or absence of macular thickening or
geographic atrophy or hemorrhage AND the level of macular degeneration
severity during one or more office visits within 12 months |
|
019 |
Diabetic
Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care |
Yes |
Process |
Percentage
of patients aged 18 years and older with a diagnosis of diabetic retinopathy
who had a dilated macular or fundus exam performed
with documented communication to the physician who manages the ongoing care
of the patient with diabetes mellitus regarding the findings of the macular
or fundus exam at least once within 12 months |
|
117 |
Diabetes:
Eye Exam |
No |
Process |
Percentage
of patients 18-75 years of age with diabetes who had a retinal or dilated eye
exam by an eye care professional during the measurement period or a negative
retinal exam (no evidence of retinopathy) in the 12 months prior to the
measurement period |
|
130 |
Documentation
of Current Medications in the Medical Record |
Yes |
Process |
Percentage
of visits for patients aged 18 years and older for which the eligible
professional or eligible clinician attests to documenting a list of current
medications using all immediate resources available on the date of the
encounter. This list must include ALL known prescriptions, over-the-counters,
herbals, and vitamin/mineral/dietary (nutritional) supplements AND must
contain the medications’ name, dosage, frequency and route of administration |
|
140 |
Age-Related
Macular Degeneration (AMD): Counseling on Antioxidant Supplement |
No |
Process |
Percentage
of patients aged 50 years and older with a diagnosis of age-related macular
degeneration (AMD) or their caregiver(s) who were counseled within 12 months
on the benefits and/or risks of the Age-Related Eye Disease Study (AREDS)
formulation for preventing progression of AMD |
|
141 |
Primary
Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR
Documentation of a Plan of Care |
Yes |
Outcome |
Percentage
of patients aged 18 years and older with a diagnosis of primary open-angle
glaucoma (POAG) whose glaucoma treatment has not failed (the most recent IOP
was reduced by at least 15% from the pre-intervention level) OR if the most
recent IOP was not reduced by at least 15% from the pre-intervention level, a
plan of care was documented within 12 months |
|
191 |
Cataracts:
20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery |
Yes |
Outcome |
Percentage
of patients aged 18 years and older with a diagnosis of uncomplicated
cataract who had cataract surgery and no significant ocular conditions
impacting the visual outcome of surgery and had best-corrected visual acuity
of 20/40 or better (distance or near) achieved within 90 days following the
cataract surgery |
|
192 |
Cataracts:
Complications within 30 Days Following Cataract Surgery Requiring Additional
Surgical Procedures |
Yes |
Outcome |
Percentage
of patients aged 18 years and older with a diagnosis of uncomplicated
cataract who had cataract surgery and had any of a specified list of surgical
procedures in the 30 days following cataract surgery which would indicate the
occurrence of any of the following major complications: retained nuclear
fragments, endophthalmitis, dislocated or wrong
power IOL, retinal detachment, or wound dehiscence |
|
226 |
Preventive
Care and Screening: Tobacco Use: Screening and Cessation Intervention |
No |
Process |
Percentage
of patients aged 18 years and older who were screened for tobacco use one or
more times within 24 months AND who received tobacco cessation intervention
if identified as a tobacco user |
|
303 |
Cataracts:
Improvement in Patient’s Visual Function within 90 Days Following Cataract
Surgery |
Yes |
Outcome |
Percentage
of patients aged 18 years and older who had cataract surgery and had
improvement in visual function achieved within 90 days following the cataract
surgery, based on completing a pre-operative and post-operative visual
function survey |
|
374 |
Closing
the Referral Loop: Receipt of Specialist Report |
Yes |
Process |
Percentage
of patients with referrals, regardless of age, for which the referring
provider receives a report from the provider to whom the patient was referred |
|
384 |
Adult
Primary Rhegmatogenous Retinal Detachment Surgery:
No Return to the Operating Room Within 90 Days of Surgery |
Yes |
Outcome |
Patients
aged 18 years and older who had surgery for primary rhegmatogenous
retinal detachment who did not require a return to the operating room within
90 days of surgery |
|
385 |
Adult
Primary Rhegmatogenous Retinal Detachment Surgery:
Visual Acuity Improvement Within 90 Days of Surgery |
Yes |
Outcome |
Patients
aged 18 years and older who had surgery for primary rhegmatogenous
retinal detachment and achieved an improvement in their visual acuity, from
their preoperative level, within 90 days of surgery in the operative eye |
|
388 |
Cataract
Surgery with Intra-Operative Complications (Unplanned Rupture of Posterior
Capsule Requiring Unplanned Vitrectomy) |
Yes |
Outcome |
Percentage
of patients aged 18 years and older who had cataract surgery performed and
had an unplanned rupture of the posterior capsule requiring vitrectomy |
|
389 |
Cataract
Surgery: Difference Between Planned and Final Refraction |
Yes |
Outcome |
Percentage
of patients aged 18 years and older who had cataract surgery performed and
who achieved a final refraction within +/- 1.0 diopters
of their planned (target) refraction |